During this educational program, the effect of GLP-RAs in patients with diabetic kidney disease (DKD) is disscussed in three lectures.

This course consists of the following lectures:

• Importance of protection and prevention in cardiorenal disease - Prof. John Deanfield, MD – London, United Kingdom
• The science behind vascular and renal benefits of GLP-1 receptor agonists - Prof. Filip Krag Knop, MD – Copenhagen, Denmark
• Clinical outcomes of GLP-1RA in kidney disease: Current evidence and ongoing trials - Frederik Persson, MD – Copenhagen, Denmark

After watching three videos on the effect of GLP-1RAs in patients with diabetic kidney disease (DKD), the learner should be able to:

• Describe how impaired kidney function affects outcomes in CVD patients
• Recall renal outcomes of trials with novel antidiabetes agents
• Explain ways to prevent and/or improve CVD and renal outcomes
• Describe what GLP-1 is and when it is secreted
• Explain how GLP-1RAs may result in CV and renal benefit
• Recall details and renal outcomes of (renal) trials evaluating GLP-1RAs

Expert faculty

• Prof. John Deanfield - Professor of Cardiology at University College London (UCL) and Consultant Cardiologist at the Barts Heart Centre (BHC) London UK. He is the Director of the National Centre for Cardiovascular disease Prevention and Outcomes (NCCPO) at UCL, and Chairman of National Institute for Cardiovascular (CV) Outcomes Research (NICOR)

• Prof. Filip Krag Knop, MD, Professor of endocrinology and Director of Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Denmark

• Frederik Persson, MD, Senior researcher at Steno Diabetes Center, Copenhagen, Denmark.

Target audience

This educational activity is designed for cardiologists in secondary care and other healthcare professionals with an interest in treating patients with diabetic kidney disease (DKD).

CME accreditation

This online course is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credit.

Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™.

Funding

Funding for this educational program was provided by an unrestricted educational grant from Novo Nordisk A/S.